Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD
Condition(s):Limbal Stem Cell DeficiencyLast Updated:October 7, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Limbal Stem Cell DeficiencyLast Updated:October 7, 2022Active, not recruiting
Condition(s):Acute-On-Chronic Liver FailureLast Updated:November 17, 2021Terminated
Condition(s):Limbal Stem Cell DeficiencyLast Updated:March 6, 2018Terminated
Condition(s):Skin Ulcer Venous Stasis ChronicLast Updated:March 22, 2024Recruiting
Condition(s):Epidermolysis BullosaLast Updated:October 30, 2023Recruiting
Condition(s):Epidermolysis BullosaLast Updated:February 24, 2023Recruiting
Condition(s):Recessive Dystrophic Epidermolysis BullosaLast Updated:October 7, 2022Completed
Condition(s):Skin Ulcer Venous Stasis ChronicLast Updated:September 10, 2020Completed
Condition(s):Diabetic Neuropathic UlcerLast Updated:September 10, 2020Completed
Condition(s):Peripheral Arterial Occlusive DiseaseLast Updated:June 29, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.